---
document_datetime: 2025-06-02 13:02:42
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/camzyos-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: camzyos-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 14.0976482
conversion_datetime: 2025-12-28 13:51:51.41134
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## CAMZYOS

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, please also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                              | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Variation type IB /  | C.I HUMAN AND VETERINARY MEDICINAL | 30/05/2025                          |                                             | SmPC and PL                      |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000266373                     | PRODUCTS - C.I.z Other variation - Accepted C.I.z - To update the heading of Figure 3 in section 4.2 of the SmPC from 'every three months' to 'subsequent visits' following the approval of the procedure EMEA/H/C/005457/II/0011. In addition, the list of local representatives in the Package Leaflet was updated with editorial and formatting corrections.                                     |            |     |
|---------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation type IA / EMA/VR/0000258170 | This was an application for a group of variations. B.II.c.1 Change in the specification parameters and/or limits of an excipient - B.II.c.1.a Tightening of specification limits - Accepted B.II.c.1 Change in the specification parameters and/or limits of an excipient - B.II.c.1.b Addition of a new specification parameter to the specification with its corresponding test method - Accepted | 12/03/2025 | N/A |
| Variation type IA / EMA/VR/0000246153 | B.III.1.b European Pharmacopoeial TSE Certificate of suitability for an active substance/starting material/reagent/ intermediate/or excipient - B.III.1.b.2 New certificate for a starting material/reagent/ intermediate/or excipient from a new or an already approved manufacturer - Accepted                                                                                                    | 23/01/2025 |     |

<div style=\"page-break-after: always\"></div>